A detailed history of Engineers Gate Manager LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 34,844 shares of MYGN stock, worth $539,733. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,844
Previous 24,130 44.4%
Holding current value
$539,733
Previous $590,000 61.53%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $256,814 - $306,420
10,714 Added 44.4%
34,844 $953,000
Q2 2024

Aug 14, 2024

BUY
$17.98 - $25.47 $433,857 - $614,591
24,130 New
24,130 $590,000
Q4 2023

Feb 14, 2024

BUY
$13.91 - $21.32 $368,211 - $564,361
26,471 Added 141.75%
45,146 $864,000
Q3 2023

Nov 14, 2023

BUY
$15.99 - $23.22 $75,696 - $109,923
4,734 Added 33.96%
18,675 $299,000
Q2 2023

Aug 14, 2023

BUY
$17.56 - $23.76 $244,803 - $331,238
13,941 New
13,941 $323,000
Q3 2022

Nov 14, 2022

SELL
$18.21 - $27.88 $2.27 Million - $3.48 Million
-124,735 Reduced 82.7%
26,093 $498,000
Q2 2022

Aug 15, 2022

BUY
$16.45 - $25.88 $2.25 Million - $3.53 Million
136,554 Added 956.66%
150,828 $2.74 Million
Q1 2022

May 16, 2022

BUY
$22.67 - $28.01 $323,591 - $399,814
14,274 New
14,274 $360,000
Q4 2021

Feb 14, 2022

SELL
$24.13 - $32.63 $1.16 Million - $1.57 Million
-48,153 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$29.97 - $36.66 $1.44 Million - $1.77 Million
48,153 New
48,153 $1.56 Million
Q4 2020

Feb 16, 2021

SELL
$12.16 - $19.77 $1.14 Million - $1.86 Million
-93,912 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$11.25 - $14.75 $1.42 Million - $1.86 Million
-126,010 Reduced 57.3%
93,912 $1.23 Million
Q2 2020

Aug 17, 2020

BUY
$10.69 - $16.49 $2.35 Million - $3.63 Million
219,922 New
219,922 $2.49 Million
Q1 2020

May 15, 2020

SELL
$9.78 - $29.53 $987,320 - $2.98 Million
-100,953 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $2.11 Million - $3.54 Million
100,953 New
100,953 $2.75 Million
Q3 2019

Nov 14, 2019

SELL
$22.08 - $47.08 $2.66 Million - $5.66 Million
-120,290 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $735,641 - $1.14 Million
32,450 Added 36.94%
120,290 $3.34 Million
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $2.37 Million - $3.05 Million
87,840 New
87,840 $2.92 Million
Q1 2018

May 07, 2018

SELL
$28.83 - $41.01 $620,796 - $883,068
-21,533 Closed
0 $0
Q4 2017

Feb 01, 2018

BUY
$28.45 - $37.14 $612,613 - $799,735
21,533
21,533 $740,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.